000 01042 a2200289 4500
005 20250515052314.0
264 0 _c20070104
008 200701s 0 0 eng d
022 _a1538-3598
024 7 _a10.1001/jama.296.24.2968
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aColón-Emeric, Cathleen S
245 0 0 _aTen vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing.
_h[electronic resource]
260 _bJAMA
_cDec 2006
300 _a2968-9 p.
_bdigital
500 _aPublication Type: Comment; Editorial
650 0 4 _aAged
650 0 4 _aAlendronate
_xtherapeutic use
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBone Density Conservation Agents
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aFractures, Bone
_xepidemiology
650 0 4 _aHumans
650 0 4 _aOsteoporosis, Postmenopausal
_xdrug therapy
773 0 _tJAMA
_gvol. 296
_gno. 24
_gp. 2968-9
856 4 0 _uhttps://doi.org/10.1001/jama.296.24.2968
_zAvailable from publisher's website
999 _c16758075
_d16758075